Primaquine Alternatives Compared
| Primaquine | Artemether / lumefantrine | Coartem (artemether / lumefantrine) |
|
|---|
| Primaquine | Artemether / lumefantrine | Coartem (artemether / lumefantrine) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Malaria, Malaria Prevention, Pneumocystis Pneumonia. Primaquine may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Malaria. Artemether / lumefantrine may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Malaria. Coartem may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||||||||||
| More about Primaquine | More about Artemether / lumefantrine | More about Coartem (artemether / lumefantrine) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Be the first to share your experience with this drug. |
Artemether / lumefantrine has an average rating of 9.0 out of 10 from a total of 10 ratings on Drugs.com. 89% of reviewers reported a positive effect, while 11% reported a negative effect. |
Coartem has an average rating of 9.7 out of 10 from a total of 7 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users * Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all Primaquine side effects |
View all Coartem side effects |
|||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
Lower cost generic |
N/A |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Primaquine prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Coartem prices |
||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||
|
N/A |
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
|
N/A |
Coartem |
N/A |
||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
|
9.6 hours |
144 hours |
144 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category N
Not classified
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 330 drugs are known to interact with Primaquine:
|
A total of 382 drugs are known to interact with Artemether / lumefantrine:
|
A total of 382 drugs are known to interact with Coartem:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
January 23, 1952 |
April 07, 2009 |
April 07, 2009 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.